Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Huang, Ping  [Clear All Filters]
2024
Zhu C, Ke S, Li Y, Zhang W, Che Y, Zhang R, Huang P, Xu T. Targeting DEP domain containing 1 in anaplastic thyroid carcinoma: Implications for stemness regulation and malignant phenotype suppression. Heliyon. 2024;10(5):e27150.
2023
Huang P, Li H, Ren L, Xie H, Chen L, Liang Y, Hu Y, Selistre-de-Araujo HSobreiro, Boussios S, Jhawar SR, et al. Astragaloside IV enhances the sensitivity of breast cancer stem cells to paclitaxel by inhibiting stemness. Transl Cancer Res. 2023;12(12):3703-3717.
Zhong H, Zhang R, Li G, Huang P, Zhang Y, Zhu J, Kuang J, Hutchins AP, Qin D, Zhu P, et al. c-JUN is a barrier in hESC to cardiomyocyte transition. Life Sci Alliance. 2023;6(11).
Zeng S, Lei S, Qu C, Wang Y, Teng S, Huang P. CRISPR/Cas-based gene editing in therapeutic strategies for beta-thalassemia. Hum Genet. 2023.
Ge L, Jin T, Zhang W, Zhang Z, Zhang Y, Hu X, Zhang W, Song F, Huang P. Identification of potential pseudogenes for predicting the prognosis of hepatocellular carcinoma. J Cancer Res Clin Oncol. 2023.
Xu T, Zhu C, Chen J, Song F, Ren X, Wang S, Yi X, Zhang Y, Zhang W, Hu Q, et al. ISG15 and ISGylation modulates cancer stem cell-like characteristics in promoting tumor growth of anaplastic thyroid carcinoma. J Exp Clin Cancer Res. 2023;42(1):182.
Song F, Zhang Q, Lu X, Xu T, Hu Q, Hu X, Fan W, Zhang Y, Huang P. Rab11-FIP4 interacts with ARF5 to promote cancer stemness in hepatocellular carcinoma. J Physiol Biochem. 2023.
2020
Yi L, Huang P, Zou X, Guo L, Gu Y, Wen C, Wu G. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer. Pharmacol Res. 2020:105144.
2015
Sang C, Zhang Y, Chen F, Huang P, Qi J, Wang P, Zhou Q, Kang H, Cao X, Guo L. Tumor necrosis factor alpha suppresses osteogenic differentiation of MSCs by inhibiting semaphorin 3B via Wnt/β-catenin signaling in estrogen-deficiency induced osteoporosis. Bone. 2015.
2014
Hale JS, Otvos B, Sinyuk M, Alvarado AG, Hitomi M, Stoltz K, Wu Q, Flavahan W, Levison B, Johansen ML, et al. Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression. Stem Cells. 2014.
Xu X, Xie G, Hu Y'nan, Li X, Huang P, Zhang H. Neural Differentiation of Mesenchymal Stem Cells Influences Their Chemotactic Responses to Stromal Cell-Derived Factor-1α. Cell Mol Neurobiol. 2014.
2013
Liu WMichael, Huang P, Kar N, Burgett M, Muller-Greven G, Nowacki AS, Distelhorst CW, Lathia JD, Rich JN, Kappes JC, et al. Lyn Facilitates Glioblastoma Cell Survival under Conditions of Nutrient Deprivation by Promoting Autophagy. PLoS One. 2013;8(8):e70804.